Leuven, Belgium - Physicians in Belgium are warning colleagues about a misdiagnosis they say may be relatively common, particularly among young patients, but easily prevented with electrophysiological ...

In many low- and middle-income countries, pediatric cardiologists can't help children with congenital heart conditions because of a critical hurdle. They don't have easy access to advanced diagnostic ...

ROCHESTER, MN — A significant number of patients given implantable cardioverter defibrillators (ICDs) for long-QT syndrome (LQTS) receive them for reasons outside of current guidelines, and many ...

Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...

LQT-1213 is a first-in-class serum glucocorticoid regulated kinase 1 inhibitor. The Food and Drug Administration (FDA) has granted Orphan Drug designation to LQT-1213, a first-in-class serum ...

Ninety-five percent of athletes with a diagnosed and treated genetic heart disease experienced no disease-triggered cardiac events, such as cardiogenic fainting or seizures, implantable ...